No results for ‘’
Lincoln Pharmaceuticals Ltd
₹618.35
(1.43%)
Thu, 03 Sept 2026, 10:51 pm
Health Technology
Pharmaceuticals: Major
24.5KLincoln Pharmaceuticals Share Price Live Chart
1 Day
(1.43%)
No Result Found
Summary
Market Cap (in Cr)
1265.68
Net Profit (in Cr)
82.35
P/B
1.64
Sector P/E
33.76
P/E
13.42
EV/EBITDA
8.73
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
13.02
ROCE
17.42
Debt/Equity
0
EPS (TTM)
43.88
Dividend Yield
0.28
Book Value
378.25
Interest Cover
59.08
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (17x coverage).
- Lincoln Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Lincoln Pharmaceuticals's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Lincoln Pharmaceuticals's earnings are expected to exceed the low risk growth rate next year.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Lincoln Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Lincoln Pharmaceuticals's earnings are expected to grow by 15.9% yearly, however this is not considered high growth (20% yearly).
- Lincoln Pharmaceuticals's earnings growth is positive but not above the India market average.
- Lincoln Pharmaceuticals's revenue is expected to grow by 13.2% yearly, however this is not considered high growth (20% yearly).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 49.78 | 49.78 | 49.78 | 49.78 | 49.78 |
| FII | 5.19 | 4.70 | 4.72 | 5.14 | 5.00 |
| DII | 1.09 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 43.94 | 45.52 | 45.49 | 45.07 | 45.22 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 758.47 | 683.52 | 645.13 | 608.57 | 570.18 | 533.62 | 458.67 |
| Fibonacci | 683.52 | 654.89 | 637.20 | 608.57 | 579.94 | 562.25 | 533.62 |
| Camarilla | 627.36 | 620.49 | 613.62 | 608.57 | 599.88 | 593.01 | 586.14 |
Pivots Level: Classic
R3
+149.90
758.47
R2
+74.95
683.52
R1
+36.57
645.13
S1
-38.38
570.18
S2
-74.95
533.62
S3
-149.90
458.67
Moving Average
Period
Value
10-EMA
614.67
20-EMA
611.38
30-EMA
610.00
50-EMA
610.65
100-EMA
608.01
200-EMA
596.11
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 28 May 2026 | board-meetings | Accounts, Quarterly Results, Dividend | |
| 12 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 29 Aug 2025 | agm | ||
| 12 Aug 2025 | dividend | Final Dividend - Rs. - 1.8 | 12 Sept 2025 |
| 22 May 2025 | dividend | ₹1.80 Dividend /Share | 12 Sept 2025 |
| 02 Sept 2024 | agm | ||
| 13 Aug 2024 | dividend | Dividend - Rs 1.80 Per Share | 14 Sept 2024 |
| 16 May 2024 | dividend | ₹1.80 Dividend /Share | 14 Sept 2024 |
| 26 Aug 2023 | agm |
Peer Comparison
Lincoln Pharmaceuticals Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
Lincoln Pharmaceuticals Ltd About
Lincoln Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1995
Headquarters
CEO
Kishorbhai M Shah
Employees
Contact
Website
http://www.lincolnpharma.com
cs@lincolnpharma.com; investor@lincolnpharma.com
Phone
91-079-67778000
Location
Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060
Lincoln Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 2014 |
|
| 2015 |
|
| 2016 |
|
| 2020 |
|
| 2021 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 208466 | 707.93 | 29 Apr 2026 |
| QE SECURITIES LLP | bulk | Buy | 109936 | 701.46 | 29 Apr 2026 |
| QE SECURITIES LLP | bulk | Sell | 106989 | 709.28 | 29 Apr 2026 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 208466 | 707.51 | 29 Apr 2026 |
| GREENX WEALTH MULTIHORIZONS OPPORTUNITY FUND | bulk | Buy | 165255 | 603.07 | 12 Feb 2026 |
| IRAGE BROKING SERVICES LLP | bulk | Buy | 92372 | 599.35 | 07 Aug 2025 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 275585 | 599.49 | 07 Aug 2025 |
| IRAGE BROKING SERVICES LLP | bulk | Buy | 137847 | 600.74 | 07 Aug 2025 |
| IRAGE BROKING SERVICES LLP | bulk | Sell | 125529 | 602.25 | 07 Aug 2025 |
| MUSIGMA SECURITIES | bulk | Buy | 160300 | 604.97 | 07 Aug 2025 |
Frequently Asked Questions
1.What is the stock price of Lincoln Pharmaceuticals Ltd?
As of 04/09/2026 at 4:21 AM, Lincoln Pharmaceuticals Ltd shares are trading at ₹618.35.
2.What is the market cap. of Lincoln Pharmaceuticals Ltd?
As of 04/09/2026, the market capitalization of Lincoln Pharmaceuticals Ltd is ₹1,217.01 crore.
3.When was Lincoln Pharmaceuticals Ltd founded?
Lincoln Pharmaceuticals Ltd was founded in 1995.
4.What are the P/E and P/B ratios of Lincoln Pharmaceuticals Ltd?
As of 04/09/2026, Lincoln Pharmaceuticals Ltd has a P/E ratio of 12.84 and a P/B ratio of 1.64.
5.How can I buy shares of Lincoln Pharmaceuticals Ltd?
You can buy shares of Lincoln Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Lincoln Pharmaceuticals Ltd?
As of March,2026, promoters hold 49.78% in Lincoln Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 5.19%, 1.09% and 43.94%, respectively.
7.Does Lincoln Pharmaceuticals Ltd pay dividends?
Yes, Lincoln Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 1.8 per share.
8.What is the dividend yield of Lincoln Pharmaceuticals Ltd?
As of 04 September, 2026, the dividend yield of Lincoln Pharmaceuticals Ltd stands at 0.30%.
9.What are the latest financial results of Lincoln Pharmaceuticals Ltd?
For January,2024, Lincoln Pharmaceuticals Ltd reported revenue of ₹616.00 crore and a net profit of ₹82.35 crore.
10.What is the Stock symbol of Lincoln Pharmaceuticals Ltd?
LINCOLN is the stock symbol of Lincoln Pharmaceuticals Ltd.
11.Who is the CEO of Lincoln Pharmaceuticals Ltd?
The CEO of Lincoln Pharmaceuticals Ltd is Kishorbhai M Shah.